(Total Views: 494)
Posted On: 06/26/2025 7:59:32 AM
Post# of 154590
Thankful no ICI's were given.
It would have gave a confusing MOA compared to mTNBC
The 2 trials fills a good info gap on PD-L1
Now we have 700mg's route on the table ---- & very, very early now. Even far quicker than the past Covid DSMB
Just like can only trust the new FDA, can only trust this CRC interim DSMB look. Dump the past, only positive 2025 set-up now until we see different
6 months behind CRC starting, but we're there now crossing the Go line & personally excited after remaining piece meal answers from the CRC abstract.....
Doubling the median survival alone, is fabulous & partner & or funding qualifying....
Our CRC & PD-L1 is outstanding...
Leronlimab always reports for duty.
It would have gave a confusing MOA compared to mTNBC
The 2 trials fills a good info gap on PD-L1
Now we have 700mg's route on the table ---- & very, very early now. Even far quicker than the past Covid DSMB
Just like can only trust the new FDA, can only trust this CRC interim DSMB look. Dump the past, only positive 2025 set-up now until we see different
6 months behind CRC starting, but we're there now crossing the Go line & personally excited after remaining piece meal answers from the CRC abstract.....
Doubling the median survival alone, is fabulous & partner & or funding qualifying....
Our CRC & PD-L1 is outstanding...
Leronlimab always reports for duty.
(6)
(0)
